Entrada Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$6,685,000 and profit margin reached -5%. Total operating expenses were $132,175,000.
Profit Margin
| 2019 | 0 | -4.64M | |
|---|---|---|---|
| 2020 | 0 | -26.37M | |
| 2021 | 0 | -50.07M | |
| 2022 | 0 | -87.45M | |
| 2023 | 129.01M | -6.68M | -5.18% |
TRDA Income Statement (2019 β 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 129.01M | 0 | 0 | 0 | 0 |
Cost of revenue | 99.88M | 1.89M | 1.11M | 326K | 104K |
Gross profit | 29.12M | -1.89M | -1.11M | -326K | -104K |
Operating exp. | |||||
Research and development | 99.88M | 66.60M | 35.92M | 21.10M | 8.21M |
Selling and marketing | -1 | 0 | 0 | 0 | 0 |
Total operating expenses | 132.17M | 97.24M | 51.12M | 26.66M | 11.82M |
Operating income | -3.16M | -97.24M | -51.12M | -26.66M | -11.82M |
Other income (expenses), net | 15.21M | 2.63M | -31K | 144K | 6.72M |
Income before tax | 12.05M | -94.61M | -51.15M | -26.52M | -5.1M |
Income tax expense | 18.74M | -7.15M | -1.08M | -144K | -451K |
Net income | -6.68M | -87.45M | -50.07M | -26.37M | -4.64M |
Earnings per share | |||||
Basic EPS | -0.2 | -2.79 | -1.6 | -0.84 | -0.15 |
Diluted EPS | -0.2 | -2.79 | -1.6 | -0.84 | -0.15 |
| Data source | Data source | Data source |